COHR renames business units

Article

Independent service organization COHR of Chatsworth, CA, announced last month new names for two of its business units. The company reported that following the separation of COHR Masterplan as a stand-alone business unit (SCAN 4/28/99), the

Independent service organization COHR of Chatsworth, CA, announced last month new names for two of its business units. The company reported that following the separation of COHR Masterplan as a stand-alone business unit (SCAN 4/28/99), the new entity will be known simply as Masterplan. COHR also appointed Bruce Cree and George Farley to Masterplan’s newly formed board of directors. Cree is Masterplan’s president and CEO, as well as chairman of the board, while Farley is vice chairman.

Another of COHR’s businesses, Purchase Connection, changed its name last month to InSource Health Services. The company announced the change at its annual meeting in New Orleans. COHR was acquired in March by Three Cities Research, an investment adviser firm in New York City (SCAN 3/17/99). The transaction made COHR a private firm.

© 1999 Miller Freeman, Inc.All rights reserved.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.